As of 2026-05-26, the Fair Value of Replicel Life Sciences Inc (RP.V) is -0.00 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.02 CAD, the upside of Replicel Life Sciences Inc is -131.42%.
With the market price of 0.02 CAD and our fair value calculation, Replicel Life Sciences Inc (RP.V) is not a good investment. Investing in RP.V stocks now will result in a potential loss of 131.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2022-03-31 | 2022-12-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | -0.16 | -0.74 | -0.05 | -0.05 | -0.04 | -0.21 |
| YoY growth | 96.16% | -375.09% | 93.22% | 7.50% | 15.59% | -32.52% |
| Market Cap (mil) | 0.72 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | -32.52% |
| TTM earnings | -0.05 |